These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2979058)
1. Radioiodinated monoclonal antibodies in the imaging and treatment of human renal cell carcinoma xenografts in nude mice. Vessella RL; Lange PH; Palme DF; Chiou RK; Elson MK; Wessels BW Targeted Diagn Ther; 1988; 1():245-82. PubMed ID: 2979058 [No Abstract] [Full Text] [Related]
2. Site-specific modification of monoclonal antibodies. Studies of 111indium-labeled antibodies using nude mouse xenograft systems. Alvarez VL; Lopes AD; Lee C; Coughlin DJ; Rodwell JD; McKearn TJ Targeted Diagn Ther; 1988; 1():283-315. PubMed ID: 2979060 [No Abstract] [Full Text] [Related]
3. The effect of antibody protein dose of anti-renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts. Kranenborg MH; Boerman OC; de Weijert MC; Oosterwijk-Wakka JC; Corstens FH; Oosterwijk E Cancer; 1997 Dec; 80(12 Suppl):2390-7. PubMed ID: 9406688 [TBL] [Abstract][Full Text] [Related]
4. The impact of tumor size on the efficacy of monoclonal antibody-targeted radiotherapy: studies using a nude mouse model with human renal cell carcinoma xenografts. Chiou RK J Urol; 1991 Jul; 146(1):232-7. PubMed ID: 2056596 [TBL] [Abstract][Full Text] [Related]
5. Radiobiological comparison of external beam irradiation and radioimmunotherapy in renal cell carcinoma xenografts. Wessels BW; Vessella RL; Palme DF; Berkopec JM; Smith GK; Bradley EW Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1257-63. PubMed ID: 2599909 [TBL] [Abstract][Full Text] [Related]
6. Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma. Divgi CR; Bander NH; Scott AM; O'Donoghue JA; Sgouros G; Welt S; Finn RD; Morrissey F; Capitelli P; Williams JM; Deland D; Nakhre A; Oosterwijk E; Gulec S; Graham MC; Larson SM; Old LJ Clin Cancer Res; 1998 Nov; 4(11):2729-39. PubMed ID: 9829736 [TBL] [Abstract][Full Text] [Related]
8. Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250. Steffens MG; Boerman OC; de Mulder PH; Oyen WJ; Buijs WC; Witjes JA; van den Broek WJ; Oosterwijk-Wakka JC; Debruyne FM; Corstens FH; Oosterwijk E Clin Cancer Res; 1999 Oct; 5(10 Suppl):3268s-3274s. PubMed ID: 10541374 [TBL] [Abstract][Full Text] [Related]
9. Radioimmunoscintigraphy and radioimmunotherapy of renal cell carcinoma xenografts. Vessella RL; Alvarez V; Chiou RK; Rodwell J; Elson M; Palme D; Shafer R; Lange P NCI Monogr; 1987; (3):159-67. PubMed ID: 3821914 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies in human renal cell carcinoma and their use in radioimmune localization and therapy of tumor xenografts. Lange PH; Vessella RL; Chiou RK; Elson MK; Moon TD; Palme D; Shafer RK Surgery; 1985 Aug; 98(2):143-50. PubMed ID: 4023915 [TBL] [Abstract][Full Text] [Related]
11. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re. Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657 [TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship. Lawrentschuk N; Davis ID; Bolton DM; Scott AM BJU Int; 2006 May; 97(5):916-22. PubMed ID: 16643471 [No Abstract] [Full Text] [Related]
13. Dosimetry and pharmacokinetics of monoclonal antibody A6H with human renal cell carcinoma xenografts: single dose study. Palme DF; Berkopec JM; Wessels BW; Elson MK; Lange PH; Vessella RL Int J Rad Appl Instrum B; 1991; 18(5):527-37. PubMed ID: 1917523 [TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy for pancreatic carcinoma using (131)I-labeled monoclonal antibody Nd2 in xenografted nude mice. Inui A; Chung YS; Sawada T; Kondo Y; Ho JJ; Kim YS; Sowa M Jpn J Cancer Res; 1996 Sep; 87(9):977-84. PubMed ID: 8878462 [TBL] [Abstract][Full Text] [Related]
15. Biodistribution and radioimmunoscintigraphy studies of renal cell carcinoma using tumor-preferential monoclonal antibodies and F(ab')2 fragments. Chiou RK J Urol; 1989 Dec; 142(6):1584-8. PubMed ID: 2585642 [TBL] [Abstract][Full Text] [Related]
16. Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors. Mach JP; Pèlegrin A; Buchegger F Curr Opin Immunol; 1991 Oct; 3(5):685-93. PubMed ID: 1755986 [TBL] [Abstract][Full Text] [Related]
17. Experimental model for radioimmunotherapy of human ovarian carcinoma with I-131-labeled monoclonal antibody OC 125. Senekowitsch R; Schmid P; Möllenstädt S; Kriegel H; Pabst HW Strahlenther Onkol; 1989 Jul; 165(7):564-6. PubMed ID: 2749501 [No Abstract] [Full Text] [Related]
18. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49. Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364 [TBL] [Abstract][Full Text] [Related]